Page last updated: 2024-11-02

phenylmethylsulfonyl fluoride and Pre-Eclampsia

phenylmethylsulfonyl fluoride has been researched along with Pre-Eclampsia in 1 studies

Phenylmethylsulfonyl Fluoride: An enzyme inhibitor that inactivates IRC-50 arvin, subtilisin, and the fatty acid synthetase complex.
phenylmethanesulfonyl fluoride : An acyl fluoride with phenylmethanesulfonyl as the acyl group.

Pre-Eclampsia: A complication of PREGNANCY, characterized by a complex of symptoms including maternal HYPERTENSION and PROTEINURIA with or without pathological EDEMA. Symptoms may range between mild and severe. Pre-eclampsia usually occurs after the 20th week of gestation, but may develop before this time in the presence of trophoblastic disease.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Waterman, IJ1
Emmison, N1
Sattar, N1
Dutta-Roy, AK1

Other Studies

1 other study available for phenylmethylsulfonyl fluoride and Pre-Eclampsia

ArticleYear
Further characterization of a novel triacylglycerol hydrolase activity (pH 6.0 optimum) from microvillous membranes from human term placenta.
    Placenta, 2000, Volume: 21, Issue:8

    Topics: Carbon Radioisotopes; Cells, Cultured; Diabetes Mellitus, Type 1; Electrophoresis, Polyacrylamide Ge

2000